Follow us:
  1. Home
  2. News
  3. Recalls

Sandoz recalls blood pressure medication

A trace amount of an impurity was found in the product

Photo
Photo source: Sandoz
Sandoz is recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets.

The blood pressure medication, manufactured by Lek Pharmaceuticals dd of Ljubljana, Slovenia, contains a trace amount of an impurity, N-nitrosodiethylamine (NDEA), which has been classified as a probable human carcinogen.

There are no reports to date of adverse events.

The recalled product, which can be identified as Losartan Potassium Hydrochlorothiazide, 100 mg/25 mg tablets in 1000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912; Exp. Date 06/2020, was shipped to distributors but not prior to October 8, 2018.

What to do

Patients with questions regarding the recall may contact Sandoz at (800) 525-8747 Monday – Friday 8:30 AM – 5:00 PM (EST) or by email at usdrugsafety.operations@novartis.com.

 

Take a Quiz

Get matched with an Accredited Partner

Share your comments

Get the news you need delivered to you

Sign up to receive our free weekly newsletter. We value your privacy. Unsubscribe easily.

You’re signed up

We’ll start sending you the news you need delivered straight to you. We value your privacy. Unsubscribe easily.